This pathology case review focuses on an aggressive, rapidly growing, ulcerated black nodule on the back of a 65-year-old man. Microscopic examination revealed a highly cellular, spindle-cell lesion exhibiting prominent central necrosis and pigmentation. The discussion centered on a critical differential diagnosis for pleomorphic spindle cell tumors of the skin, including metastatic melanoma, atypical fibroxanthoma (AFX)/pleomorphic dermal sarcoma (PDS), spindle cell squamous cell carcinoma (SCC), and spindle cell angiosarcoma. The presenters emphasized the necessary immunohistochemistry panel (Keratin, S100/SOX10, vascular markers) required for accurate subtyping. The final diagnosis was confirmed as a high-grade spindle cell melanoma, highlighted by diffuse S100 and SOX10 positivity, along with aggressive features such as necrosis, which suggests a poor prognosis and distinguishes it from desmoplastic melanoma.
Summary of Pathology Case Review: Ulcerated Spindle Cell Tumor
0:13 Case Presentation: The case involves a 65-year-old man presenting with a rapidly growing, ulcerated black nodule on his back.
0:26 Microscopic Findings: The lesion is highly cellular, relatively well-circumscribed, and shows significant ulceration. A central area of necrosis (ghost outlines of dead cells) is prominent. The cells themselves are spindly and highly pigmented.
1:24 Initial Differential Diagnosis: The differential includes metastatic melanoma, spindle cell angiosarcoma, and atypical fibroxanthoma (AFX).
1:52 Key Takeaway for Sarcomas: The pathologist stresses the need to include vascular markers (like ERG or CD31) in the panel for any malignant spindle cell tumor, as small shave biopsies might miss vascular channels necessary to diagnose an aggressive angiosarcoma.
2:47 Defining High-Grade AFX: The discussion clarifies that Pleomorphic Dermal Sarcoma (PDS) is essentially AFX with high-risk features, such as size greater than 2cm, deep involvement (subcutis), necrosis, or vascular/perineural invasion.
3:31 Core Diagnostic Panel: A standard panel for malignant pleomorphic spindle cell tumors includes markers for squamous differentiation (Keratin, p63/p40), melanocytic differentiation (S100, SOX10), and often vascular markers.
4:14 Melanoma Marker Note: Highly spindled melanomas often lose expression of specific markers like MART-1/Melan-A and HMB45, but typically retain S100 and SOX10 positivity.
5:08 Confirmed Diagnosis: Based on morphology (fascicles) and immunohistochemistry (diffusely S100 and SOX10 positive), the tumor is diagnosed as Spindle Cell Melanoma.
5:22 Prognosis: The presence of necrosis and atypical mitotic figures indicates a highly aggressive tumor and a poor prognosis.
5:35 Spindle vs. Desmoplastic Melanoma: Spindle cell melanoma is highly cellular, in contrast to desmoplastic melanoma, which is hypocellular and hypocollagenized. A diagnosis of "pure" desmoplastic melanoma requires at least 90% of the tumor to exhibit that component.
6:24 Consideration of Metastasis: The lack of an in situ component raises the possibility of metastatic melanoma. However, very large, ulcerated primary melanomas (especially spindle or desmoplastic types) often lack a clear in situ component.
7:37 Aggressiveness Indicated by Necrosis: Tumor necrosis is generally uncommon in primary cutaneous melanomas unless the tumor is extremely large and bulky, confirming the highly aggressive nature of this particular lesion.